Dr. W. David Hardy to Lead ARA as New Chairman of the BoardReturn to The Insider: News & Views
September 30 2013
AIDS Research Alliance is pleased to announce that Dr. W. David Hardy, Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA, and formerly the Director of the Division of Infectious Diseases at Cedars-Sinai Medical Center, has officially accepted the role of Chairman of the Board of AIDS Research Alliance.
In this capacity, Dr. Hardy will bring considerable expertise, borne of a long and distinguished career in HIV/AIDS research and treatment, to ARA. He will work closely with ARA Medical Director Dr. Stephen Brown and ARA CEO Carolyn Carlburg to harness the scientific knowledge and financial support necessary to advance the development of prostratin, ARA’s HIV cure research strategy, to clinical trials.
Early in the AIDS epidemic, Dr. Hardy completed a fellowship in infectious diseases/clinical immunology at the UCLA School of Medicine, mentored by Michael Gottlieb, MD, also a long-time friend to ARA, and the physician who first identified and reported AIDS as a new disease. Fifteen years later, Dr. Hardy returned to UCLA and completed post-doctoral training in HIV laboratory research with Irvin Chen, PhD at the UCLA School of Medicine. Since completing his medical training, Dr. Hardy has devoted his entire career to HIV/AIDS research and treatment.
“I have known, respected, and supported AIDS Research Alliance for over 20 years,” said Dr. Hardy. “I was involved with the organization back in the late 1980s as part of its Medical Advisory Committee. Joining the Board and assuming the role of Chairman is an enhancement of my involvement. It provides me with a way to help support what I consider the greatest challenge in HIV research: Curing HIV”
Dr. Hardy will succeed Cary Stevens, who chaired the Board for the previous six years. Under Mr. Stevens’ leadership, ARA weathered the Great Recession, the worst economic crisis since the Great Depression of the 1930s. He also oversaw ARA’s relocation from West Hollywood to Metro Los Angeles, the new ground zero for the HIV/AIDS epidemic.
“Cary Stevens worked tirelessly as the Board Chairman, leading AIDS Research Alliance through some very challenging times,” explained ARA CEO Carolyn Carlburg. “Without his leadership, generosity and foresight, ARA may not have made it through our relocation, which required extensive financial and logistical planning.”
“We are very pleased that Cary will remain on our Board, and we look forward to working with Dr. Hardy as ARA charts a future that involves crafting a new strategic plan, advancing our cure research targeting the HIV reservoirs, and finding ever new ways to fund our important work.”